✦ LIBER ✦

The Role of Vandetanib in the Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Four Randomized Controlled Trials

✍ Scribed by Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Zan Shen; Yang Yao

Publisher: Springer
Year: 2011
Tongue: English
Weight: 320 KB
Volume: 189
Category: Article
ISSN: 0341-2040
DOI: 10.1007/s00408-011-9332-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of docetaxel-based doublet

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer

✍ Wei-Xiang Qi; Zan Shen; Yang Yao 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 382 KB

Cetuximab-based Therapy is Effective in

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair; Osama A. Al-Masri; Najeeb C. Chaudry 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

A randomized trial of three cisplatin-co

A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

✍ Lucio Crino; Maurizio Tonato; Samir Darwish; Maria L. Meacci; Enrichetta Corgna; 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 485 KB

Does maintenance/consolidation chemother

Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? : A metaanalysis of the published randomized controlled trials

✍ Hakan Bozcuk; Mehmet Artac; Mustafa Ozdogan; Burhan Savas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received